Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials

Published:2023-05-05 Issue:6 Volume:25 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Tang Hui-Jun¹,Bie Cai-Qun¹,Guo Li-Liangzi²,Zhong Li-Xian²,Tang Shao-Hui²

Affiliation:

1. Department of Gastroenterology, Shenzhen Integrated Traditional Chinese and Western Medicine Hospital, Shenzhen, Guangdong 518104, P.R. China

2. Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510632, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference43 articles.

1. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease;Seyedian;J Med Life,2019

2. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults;Lamb;Gut,2019

3. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review;Jeong;Autoimmun Rev,2019

4. Systematic review with network meta-analysis: First-and second-line pharmacotherapy for moderate-severe ulcerative colitis;Singh;Aliment Pharmacol Ther,2018

5. An overview of the mechanism of action of the monoclonal antibody vedolizumab;Wyant;J Crohns Colitis,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis;International Journal of Molecular Sciences;2023-09-04